Shanghai Best-Link Bioscience

Shanghai Best-Link Bioscience

Private
ShanghaiHealthcare & Life Scienceshttp://bestlinkbio.com/

Last Round

Series B

Jan 28, 2024

Total Funding Raised

$67.12M

Company Overview

Shanghai Best-Link Bioscience is a biotechnology company that develops innovative drugs for tumor therapy. The company's products are based on a nano-conjugate drug platform (NMPDC®) and a precise drug delivery system designed for precision oncology and tumor immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

nano-conjugate drugsdrug delivery platformprecision oncologynanomedicinesolid tumor treatmenttumor immunotherapypolymer-drug conjugatestumor microenvironmentdrug discoveryclinical-stage biotechdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Best-Link Bioscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanghai Best-Link Bioscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJan 28, 2024
Series AApr 8, 2023
AngelJun 10, 2021

Shanghai Best-Link Bioscience Investors

Notable investors and investment history

InvestorRounds
Lapam CapitalSeries B, Series A
Tigeryeah CapitalSeries B, Series A
Zhongke ChuangxingSeries B
Yonghua CapitalSeries B
Hyfinity InvestmentsSeries A

Shanghai Best-Link Bioscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Best-Link Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Best-Link Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2021
Last FundingJan 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.